Výsledky vyhľadávania - "Neoplasms, Second Primary/therapy"

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS

Autori: Gail J. Roboz M.G. Della Porta Francesc Cobo a ďalší

Prispievatelia: Gail J. Roboz M.G. Della Porta Francesc Cobo a ďalší

Zdroj: Leukemia
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
LEUKEMIA
r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Institut de Recerca Germans Trias i Pujol (IGTP)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Instituto de Investigación Sanitaria La Fe (IIS La Fe)
Kuendgen, A, Nomdedeu, M, Tuechler, H, Garcia-Manero, G, Komrokji, R S, Sekeres, M A, Della Porta, M G, Cazzola, M, DeZern, A E, Roboz, G J, Steensma, D P, Van de Loosdrecht, A A, Schlenk, R F, Grau, J, Calvo, X, Blum, S, Pereira, A, Valent, P, Costa, D, Giagounidis, A, Xicoy, B, Döhner, H, Platzbecker, U, Pedro, C, Lübbert, M, Oiartzabal, I, Díez-Campelo, M, Cedena, M T, Machherndl-Spandl, S, López-Pavía, M, Baldus, C D, Martinez-de-Sola, M, Stauder, R, Merchan, B, List, A, Ganster, C, Schroeder, T, Voso, M T, Pfeilstöcker, M, Sill, H, Hildebrandt, B, Esteve, J, Nomdedeu, B, Cobo, F, Haas, R, Sole, F, Germing, U, Greenberg, P L, Haase, D & Sanz, G 2021, 'Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS', Leukemia, vol. 35, no. 3, pp. 835-849. https://doi.org/10.1038/s41375-020-0917-7
Leukemia, vol. 35, no. 3, pp. 835-849

Predmety: Female [MeSH], Follow-Up Studies [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Neoplasms, Second Primary/classification [MeSH], Humans [MeSH], Myelodysplastic Syndromes/therapy [MeSH], Neoplasms, Second Primary/diagnosis [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Risk factors, Survival Rate [MeSH], Article, Male [MeSH], Neoplasms, Second Primary/therapy [MeSH], Prognosis [MeSH], Diagnosis, Myelodysplastic Syndromes/classification [MeSH], Biomarkers, Tumor/analysis [MeSH], Myelodysplastic Syndromes/diagnosis [MeSH], Risk Assessment/methods [MeSH], Male, Displàsia, Risk Assessment, 03 medical and health sciences, 0302 clinical medicine, Biomarkers, Tumor, Humans, 10. No inequality, Aged, Aged, 80 and over, Biomarkers, Tumor/analysis, Female, Follow-Up Studies, Middle Aged, Myelodysplastic Syndromes/classification, Myelodysplastic Syndromes/diagnosis, Myelodysplastic Syndromes/therapy, Neoplasms, Second Primary/classification, Neoplasms, Second Primary/diagnosis, Neoplasms, Second Primary/therapy, Prognosis, Retrospective Studies, Risk Assessment/methods, Survival Rate, Neoplasms, Second Primary, 3. Good health, Classificació, Settore MED/15 - MALATTIE DEL SANGUE, Myelodysplastic Syndromes, Síndromes mielodisplàsiques

Popis súboru: application/pdf; pdf

Prístupová URL adresa: https://www.nature.com/articles/s41375-020-0917-7.pdf
https://pubmed.ncbi.nlm.nih.gov/32595214
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4456
https://i3pt.portalinvestigacion.com/publicaciones/2606
https://hdl.handle.net/20.500.12530/62309
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13325
https://art.torvergata.it/handle/2108/261801
https://mdanderson.elsevierpure.com/en/publications/therapy-related-myelodysplastic-syndromes-deserve-specific-diagno
https://www.narcis.nl/publication/RecordID/oai%3Apure.atira.dk%3Apublications%2F52973e05-c713-488d-ba07-abb932baceee
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932916
https://repositori.upf.edu/handle/10230/46100
https://www.nature.com/articles/s41375-020-0917-7
https://research.vumc.nl/en/publications/52973e05-c713-488d-ba07-abb932baceee
https://pure.amsterdamumc.nl/en/publications/74dfc44b-2693-4eba-b88e-9a1abf97129d
https://doi.org/10.1038/s41375-020-0917-7
https://resolver.sub.uni-goettingen.de/purl?gro-2/84111
https://resolver.sub.uni-goettingen.de/purl?gro-2/133847
https://serval.unil.ch/notice/serval:BIB_389289378560
https://serval.unil.ch/resource/serval:BIB_389289378560.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_3892893785601
https://repository.publisso.de/resource/frl:6471060

Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in France

Autori: Romaric Loffroy Maxime Ronot Michel Greget a ďalší

Prispievatelia: Romaric Loffroy Maxime Ronot Michel Greget a ďalší

Zdroj: Cardiovasc Intervent Radiol
Dadun. Depósito Académico Digital de la Universidad de Navarra
Universidad de Navarra
Cardiovascular and interventional radiology, vol. 44, no. 1, pp. 36-49

Predmety: Male, 0301 basic medicine, Yttrium-90, Cardiac & Cardiovascular Systems, Carcinoma, Hepatocellular, Transarterial radioembolization, SIR-spheres, 03 medical and health sciences, MICROSPHERES, 0302 clinical medicine, Carcinoma, Hepatocellular/diagnosis, Carcinoma, Hepatocellular/epidemiology, Carcinoma, Hepatocellular/therapy, Embolization, Therapeutic/methods, Female, France/epidemiology, Humans, Incidence, Liver Neoplasms/diagnosis, Liver Neoplasms/epidemiology, Liver Neoplasms/therapy, Neoplasms, Second Primary/diagnosis, Neoplasms, Second Primary/epidemiology, Neoplasms, Second Primary/therapy, Quality of Life, Yttrium Radioisotopes/therapeutic use, Interim analysis, Radioembolization, SIRT, HEPATOCELLULAR-CARCINOMA, Yttrium Radioisotopes, Clinical Investigation, 1102 Cardiorespiratory Medicine and Haematology, Science & Technology, [PHYS.PHYS.PHYS-BIO-PH] Physics [physics]/Physics [physics]/Biological Physics [physics.bio-ph], INTERNAL RADIATION-THERAPY, Radiology, Nuclear Medicine & Medical Imaging, Liver Neoplasms, CIRT-FR Principal Investigators, Neoplasms, Second Primary, Embolization, Therapeutic, 3. Good health, SORAFENIB, EORTC, Nuclear Medicine & Medical Imaging, Cardiovascular System & Cardiology, TRIAL, France, 3201 Cardiovascular medicine and haematology, Life Sciences & Biomedicine

Popis súboru: application/pdf

Prístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00270-020-02643-x.pdf
https://pubmed.ncbi.nlm.nih.gov/32975600
https://hdl.handle.net/10171/115046
https://pubmed.ncbi.nlm.nih.gov/32975600/
https://link.springer.com/article/10.1007/s00270-020-02643-x
https://link.springer.com/content/pdf/10.1007/s00270-020-02643-x.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728633
https://europepmc.org/article/PMC/PMC7728633
https://serval.unil.ch/resource/serval:BIB_8216514E3692.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_8216514E36921
https://serval.unil.ch/notice/serval:BIB_8216514E3692